FDA approves Lymphoseek

FDA approved an NDA for Lymphoseek tilmanocept from Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB) for use in intraoperative lymphatic imaging in breast cancer and melanoma patients. On a conference ca...